Trial Profile
Testosterone Supplementation in Men with MCI.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism; Mild cognitive impairment
- Focus Biomarker; Therapeutic Use
- Acronyms HIP
- 18 Jun 2012 Actual patient number 23 added as reported by ClinicalTrials.gov.
- 18 Jun 2012 Actual end date (1 May 2012) added as reported by ClinicalTrials.gov.
- 18 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.